# PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011

> **NCT02039960** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT02039960
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2016-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039960, "PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02039960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*